Alveolar hypoventilation and cor pulmonale secondary to damage to the respiratory center∗

1961 ◽  
Vol 8 (3) ◽  
pp. 416-419 ◽  
Author(s):  
Richard L. Naeye
1957 ◽  
Vol 256 (25) ◽  
pp. 1165-1170 ◽  
Author(s):  
Tor Richter ◽  
John R. West ◽  
Alfred P. Fishman

1957 ◽  
Vol 54 (3) ◽  
pp. 319-341 ◽  
Author(s):  
Alberto C. Taquini ◽  
Aquiles J. Roncoroni ◽  
Pedro Aramendía ◽  
Antonio M. Ros

2016 ◽  
Vol 65 (3) ◽  
Author(s):  
D. Samolski ◽  
A. Antón ◽  
M. Mayos ◽  
M. Subirana ◽  
R. Güell

The association of primary alveolar hypoventilation (PAH) and chromosomic diseases has not been described previously. A 19 year-old man with Fraccaro’s syndrome (XXXXY karyotype) was admitted to evaluate chronic hypercapnic respiratory failure, pulmonary arterial hypertension and cor pulmonale. PAH was diagnosed. As effective treatment, such as non-invasive positive pressure ventilation (NIPPV), is available for this disorder we should intensify the search for PAH in patients with chromosome disease.


PEDIATRICS ◽  
1977 ◽  
Vol 59 (2) ◽  
pp. 288-292
Author(s):  
Roland D. Eavey ◽  
Angelo Casagrande ◽  
Bruce Blasberg ◽  
Sylvan E. Stool

The spectrum of symptoms of chronic upper airway obstruction ranges widely from merely annoying "noisy respirations" to death from heart failure secondary to cor pulmonale.1 The latter condition occurs because airway obstruction can lead to alveolar hypoventilation which results in hypoxia, hypercapnia, and acidosis which, in turn, produce pulmonary arteriolar construction.2 Chronic upper airway obstruction can also be a management problem for the pediatrician. Depending on the etiology and degree of symptoms, three treatment choices are usually considered: medical management, corrective surgery to recreate an airway; or tracheotomy to bypass the obstruction. We recently have seen a patient who demostrated chronic respiratory difficulty and ECG evidence of early right heart failure who benefited greatly by the use of a simple dental appliance.


1962 ◽  
Vol 32 (2) ◽  
pp. 208-217 ◽  
Author(s):  
Theodore Rodman ◽  
Myron E Resnick ◽  
Richard D Berkowitz ◽  
Joseph F Fennelly ◽  
Joseph Olivia

2013 ◽  
Vol 52 (191) ◽  
Author(s):  
Jing Zhang ◽  
Yan Wang ◽  
Jing Feng ◽  
Xin Sun

Chronic obstructive pulmonary disease is a leading cause of morbidity and mortality worldwide.Sleep-induced hypoxemia is defined as “an SpO2 (oxyhemoglobin saturation) during sleep of <90% for more than five minutes with a nadir of at least 85%” or “> 30% of total sleep time with anSpO2 of < 90%” in subject with a baseline awake SpO2 of ≥ 90%. Patients with moderate or severeCOPD run a high risk of developing SIH mainly because of alveolar hypoventilation and ventilationperfusionmismatch. Compared to their non-SIH brethren, SIH COPD patients have greater degreesof pulmonary hypertension and cor pulmonale, require more frequent hospitalizations, and sustainhigher mortality rates. And the necessity of treatment of isolated SIH in COPD has been debatedfor years. In this mini review, the definition, reasons, prevalence, clinical significance and treatmentapproaches of SIH in COPD are summarized._______________________________________________________________________________________Keywords: chronic obstructive pulmonary disease; polysomnography; rapid eye movement;sleep-induced hypoxemia.


1969 ◽  
Vol 55 (2) ◽  
pp. 110-114 ◽  
Author(s):  
R.A. Massumi ◽  
R.K. Sarin ◽  
M. Pooya ◽  
T.R. Reichelderfer ◽  
J.R. Fraga ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document